Role of endoscopic ultrasound and endoscopic ultrasound-guided fine-needle aspiration in diagnosing metastasis to the pancreas: A tertiary center experience

Pancreatology

Volumn 11, Issue 4, 2011, Pages 390-398

  Hijioka, S ^c   Matsuo, K ^c   Mizuno, N ^c   Hara, K ^c   Mekky, M A ^a   Vikram, B ^b   Hosoda, W ^c   Yatabe, Y ^c   Shimizu, Y ^c   Kondo, S ^c   Tajika, M ^c   Niwa, Y ^c   Tamada, K ^d   Yamao, K ^c  

^a Assiut University Faculty of Medicine   (Egypt)

^b INSTITUTE OF LIVER AND BILIARY SCIENCES   (India)

^c AICHI CANCER CENTER HOSPITAL   (Japan)

^d JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Endoscopic ultrasound; Endoscopic ultrasound guided fine needle aspiration; Metastasis to pancreas

Indexed keywords

K RAS PROTEIN;

ADULT; ARTICLE; ASPIRATION BIOPSY; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENDOSCOPIC ECHOGRAPHY; FEMALE; GENE MUTATION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; ONCOGENE K RAS; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS CYST; PANCREAS METASTASIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 80052336719     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000330536     Document Type: Article

References (27)

1. Fritscher-Ravens A, Sriram PV, Krause C, et al: Detection of pancreatic metastases by EUS-guided fine-needle aspiration. Gastrointest Endosc 2001; 53: 65-70. (Pubitemid 32109452)
2. Bechade D, Palazzo L, Fabre M, Algayres JP: EUS-guided FNA of pancreatic metastasis from renal cell carcinoma. Gastrointest Endosc 2003; 58: 784-788. (Pubitemid 37370500)
3. DeWitt J, Jowell P, Leblanc J, et al: EUS-guided FNA of pancreatic metastases: a multicenter experience. Gastrointest Endosc 2005; 61: 689-696. (Pubitemid 40603037)
4. Mallery JS, Centeno BA, Hahn PF, Chang Y, Warshaw AL, Brugge WR: Pancreatic tissue sampling guided by EUS, CT/US, and surgery: a comparison of sensitivity and specificity. Gastrointest Endosc 2002; 56: 218-224.
5. Eloubeidi M, Chen V, Eltoum I, et al: Endoscopic ultrasound-guided fine needle aspiration biopsy of patients with suspected pancreatic cancer: diagnostic accuracy and acute and 30-day complications. Am J Gastroenterol 2003; 98: 2663-2668. (Pubitemid 38020105)
6. Malfertheiner S: Role of endoscopic ultrasound in the diagnosis of patients with solid pancreatic masses. Dig Dis 2004; 22: 26-31.
7. Hijioka S, Hifumi M, Mekky MA, et al: Total pancreatectomy for metastatic renal cell carcinoma with marked extension into the main pancreatic duct. Intern Med 2010; 49: 557-562.
8. Sellner F, Tykalsky N, De Santis M, Pont J, Klimpfinger M: Solitary and multiple isolated metastases of clear cell renal carcinoma to the pancreas: an indication for pancreatic surgery. Ann Surg Oncol 2006; 13: 75-85. (Pubitemid 43117648)
9. Minni F, Casadei R, Perenze B, et al: Pancreatic metastases: observations of three cases and review of the literature. Pancreatology 2004; 4: 509-520. (Pubitemid 40091400)
10. Yamao K, Sawaki A, Mizuno N, Shimizu Y, Yatabe Y, Koshikawa T: Endoscopic ultrasound- guided fine-needle aspiration biopsy (EUS-FNAB): past, present, and future. J Gastroenterol 2005; 40: 1013-1023. (Pubitemid 43055284)
11. Yamao K, Mizuno N, Takagi T, Hara K: How I do it and when I use (and do not use) EUSFNA. Gastrointest Endosc 2009; 69:S134-S137.
12. Hosoda W, Takagi T, Mizuno N, et al: Diagnostic approach to pancreatic tumors with the specimens of endoscopic ultrasoundguided fine needle aspiration. Pathol Int 2010; 60: 358-364.
13. Terminology and Diagnostic Criteria Committee JSoU, Medicine I: Diagnostic Criteria for Pancreatic Cancer. Jpn J Med Ultrasonics 1996; 23: 52-56.
14. Roland CF, van Heerden JA: Nonpancreatic primary tumors with metastasis to the pancreas. Surg Gynecol Obstet 1989; 168: 345-347. (Pubitemid 19120574)
15. Z'Graggen K, Fernandez-del Castillo C, Rattner DW, Sigala H, Warshaw AL: Metastases to the pancreas and their surgical extirpation. Arch Surg 1998; 133: 413-417, 418-419.
16. Dim DC, Nugent SL, Darwin P, Peng HQ: Metastatic merkel cell carcinoma of the pancreas mimicking primary pancreatic endocrine tumor diagnosed by endoscopic ultrasound- guided fine needle aspiration cytology: a case report. Acta Cytol 2009; 53: 223-228.
17. Reddy S, Wolfgang CL: The role of surgery in the management of isolated metastases to the pancreas. Lancet Oncol 2009; 10: 287-293.
18. Showalter SL, Hager E, Yeo CJ: Metastatic disease to the pancreas and spleen. Semin Oncol 2008; 35: 160-171. (Pubitemid 351469911)
19. Palmowski M, Hacke N, Satzl S, et al: Metastasis to the pancreas: characterization by morphology and contrast enhancement features on CT and MRI. Pancreatology 2008; 8: 199-203. (Pubitemid 351670370)
20. Dennis JL, Hvidsten TR, Wit EC, et al: Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm. Clin Cancer Res 2005; 11: 3766-3772. (Pubitemid 40685594)
21. Ordonez NG: Thyroid transcription factor-1 is a marker of lung and thyroid carcinomas. Adv Anat Pathol 2000; 7: 123-127.
22. De Lott L, Morrison C, Suster S, Cohn D, Frankel W: CDX2 is a useful marker of intestinal- type differentiation: a tissue microarray- based study of 629 tumors from various sites. Arch Pathol Lab Med 2009; 129: 1100-1105. (Pubitemid 41242420)
23. Matsubayashi H, Watanabe H, Ajioka Y, et al: Different amounts of K-ras mutant epithelial cells in pancreatic carcinoma and mass-forming pancreatitis. Pancreas 2000; 21: 77-85. (Pubitemid 30421938)
24. Berrozpe G, Schaeffer J, Peinado M, Real F, Perucho M: Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer. Int J Cancer 1994; 58: 185-191. (Pubitemid 24240093)
25. Tada M, Omata M, Ohto M: Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma. Gastroenterology 1991; 100: 233-238.
26. Khalid A, Nodit L, Zahid M, et al: Endoscopic ultrasound fine needle aspirate DNA analysis to differentiate malignant and benign pancreatic masses. Am J Gastroenterol 2006; 101: 2493-2500. (Pubitemid 44665243)
27. Santini D, Loupakis F, Vincenzi B, et al: High concordance of KRAS status between primary colorectal tumors and related metastatic sites: implications for clinical practice. Oncologist 2008; 13: 1270-1275.